Its stock is currently trading at approximately 32% discount to its fair value estimate. It is big, diverse and known, and most importantly it will hold on to its patents until 2028. I think it may actually be a good medium-time investment. One should, however, keep track of new patents vs. expiring old ones. Bad timing between the two can cause a sharp decline in stock price.
There are no replies in this thread yet. Be the first to post a reply below: